Iben Kümler
Clinical Associate Professor
1 - 4 out of 4Page size: 10
- 2023
- Published
A nationwide observational study in heavily pretreated metastatic HER2-positive breast cancer patients
Due, A., Berg, T., Jensen, M. B., Yammeni, S., Volmer, L., Brems-Eskildsen, A. S., Andersen, K. K., Rana, S., Knoop, A. & Kümler, Iben, 2023, In: Acta Oncologica. 62, 2, p. 126-133 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
A retrospective, non-interventional study of breast cancer patients diagnosed with ER+/HER2 negative, locally advanced or metastatic breast cancer treated with palbociclib in Denmark
Garly, R., Berg, T., Jensen, M. B., Knoop, A., Volmer, L., Glavicic, V., Khan, H., Poulsen, P. B., Olsen, J. & Kümler, Iben, 2023, In: Acta Oncologica. 62, 3, p. 290-297 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Adjuvant treatment with trastuzumab of patients with HER2-positive, T1a-bN0M0 breast tumors: A systematic review and meta-analysis
Hassing, C. M. S., Nielsen, Dorte Lisbet, Knoop, A. S., Tvedskov, Tove Filtenborg, Kroman, Niels Thorndahl, Lænkholm, Anne-Vibeke, Juhl, C. B. & Kümler, Iben, 2023, In: Critical Reviews in Oncology/Hematology. 184, 11 p., 103952.Research output: Contribution to journal › Review › Research › peer-review
- Published
Real-world survival of Danish patients with HER2-positive metastatic breast cancer
Artzi, D., Berg, T., Celik, A., Kümler, Iben, Kenholm, J., Al-Rawi, S., Jensen, M. B., Andersson, M. & Knoop, A., 2023, In: Acta Oncologica. 62, 6, p. 601-607 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 40449305
Most downloads
-
404
downloads
A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a study protocol
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
12
downloads
Adjuvant treatment with trastuzumab of patients with HER2-positive, T1a-bN0M0 breast tumors: A systematic review and meta-analysis
Research output: Contribution to journal › Review › Research › peer-review
Published